

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.24366128 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.21779958 |
| 3 | vocalization behavior (GO:0071625) | 4.95102601 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 4.86115534 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.70851883 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.66434841 |
| 7 | protein localization to synapse (GO:0035418) | 4.56263609 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.55932295 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.55040445 |
| 10 | synaptic vesicle maturation (GO:0016188) | 4.49545930 |
| 11 | glutamate secretion (GO:0014047) | 4.45410616 |
| 12 | locomotory exploration behavior (GO:0035641) | 4.41640886 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.34877036 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.07919712 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 4.05357687 |
| 16 | neuronal action potential propagation (GO:0019227) | 4.02332954 |
| 17 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.00790809 |
| 18 | neurotransmitter secretion (GO:0007269) | 3.91129263 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.88959603 |
| 20 | layer formation in cerebral cortex (GO:0021819) | 3.86981552 |
| 21 | neuron-neuron synaptic transmission (GO:0007270) | 3.77317477 |
| 22 | neuron recognition (GO:0008038) | 3.75835940 |
| 23 | exploration behavior (GO:0035640) | 3.75606713 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.72050533 |
| 25 | positive regulation of synapse maturation (GO:0090129) | 3.71210256 |
| 26 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.70660249 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 3.67588123 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 3.67311405 |
| 29 | glutamate receptor signaling pathway (GO:0007215) | 3.63237872 |
| 30 | response to histamine (GO:0034776) | 3.61122346 |
| 31 | synaptic vesicle endocytosis (GO:0048488) | 3.59722286 |
| 32 | neural tube formation (GO:0001841) | 3.57893330 |
| 33 | drug catabolic process (GO:0042737) | 3.57247305 |
| 34 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.54075401 |
| 35 | indole-containing compound catabolic process (GO:0042436) | 3.50803745 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 3.50803745 |
| 37 | tryptophan catabolic process (GO:0006569) | 3.50803745 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 3.50370758 |
| 39 | presynaptic membrane assembly (GO:0097105) | 3.49963344 |
| 40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.46354260 |
| 41 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.41953791 |
| 42 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.39070689 |
| 43 | presynaptic membrane organization (GO:0097090) | 3.38769165 |
| 44 | long-term synaptic potentiation (GO:0060291) | 3.38107118 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.37848667 |
| 46 | positive regulation of membrane potential (GO:0045838) | 3.35994464 |
| 47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.35736926 |
| 48 | postsynaptic membrane organization (GO:0001941) | 3.35682580 |
| 49 | neurotransmitter transport (GO:0006836) | 3.34828216 |
| 50 | protein K11-linked deubiquitination (GO:0035871) | 3.34183320 |
| 51 | axonal fasciculation (GO:0007413) | 3.33638152 |
| 52 | proline transport (GO:0015824) | 3.33288896 |
| 53 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.32199097 |
| 54 | establishment of protein localization to Golgi (GO:0072600) | 3.32191074 |
| 55 | exogenous drug catabolic process (GO:0042738) | 3.26542792 |
| 56 | righting reflex (GO:0060013) | 3.26484902 |
| 57 | transmission of nerve impulse (GO:0019226) | 3.25980929 |
| 58 | long-term memory (GO:0007616) | 3.25713956 |
| 59 | regulation of postsynaptic membrane potential (GO:0060078) | 3.25542405 |
| 60 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.20557751 |
| 61 | regulation of synaptic plasticity (GO:0048167) | 3.19210148 |
| 62 | behavioral response to cocaine (GO:0048148) | 3.18951659 |
| 63 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.17630021 |
| 64 | detection of calcium ion (GO:0005513) | 3.14420333 |
| 65 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.10105771 |
| 66 | regulation of neurotransmitter secretion (GO:0046928) | 3.09844758 |
| 67 | activation of protein kinase A activity (GO:0034199) | 3.09412475 |
| 68 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.08617638 |
| 69 | membrane hyperpolarization (GO:0060081) | 3.05039208 |
| 70 | regulation of neurotransmitter levels (GO:0001505) | 3.03870369 |
| 71 | regulation of vesicle fusion (GO:0031338) | 3.00829665 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 3.00572441 |
| 73 | regulation of synapse maturation (GO:0090128) | 3.00139227 |
| 74 | regulation of glutamate secretion (GO:0014048) | 2.99717116 |
| 75 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.98901172 |
| 76 | innervation (GO:0060384) | 2.98332059 |
| 77 | synapse assembly (GO:0007416) | 2.97906600 |
| 78 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.97236473 |
| 79 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.96603292 |
| 80 | behavioral fear response (GO:0001662) | 2.96088471 |
| 81 | behavioral defense response (GO:0002209) | 2.96088471 |
| 82 | negative regulation of neurotransmitter transport (GO:0051589) | 2.94969358 |
| 83 | gamma-aminobutyric acid transport (GO:0015812) | 2.94883993 |
| 84 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.94211136 |
| 85 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.94211136 |
| 86 | cellular ketone body metabolic process (GO:0046950) | 2.93985063 |
| 87 | nucleobase catabolic process (GO:0046113) | 2.92858018 |
| 88 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.91507340 |
| 89 | regulation of neurotransmitter transport (GO:0051588) | 2.91127351 |
| 90 | cerebellar granule cell differentiation (GO:0021707) | 2.90310037 |
| 91 | cellular potassium ion homeostasis (GO:0030007) | 2.90247377 |
| 92 | positive regulation of synapse assembly (GO:0051965) | 2.90136105 |
| 93 | mating behavior (GO:0007617) | 2.90064887 |
| 94 | auditory behavior (GO:0031223) | 2.89927647 |
| 95 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.89855341 |
| 96 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.89829787 |
| 97 | bile acid biosynthetic process (GO:0006699) | 2.89005589 |
| 98 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.88864765 |
| 99 | glyoxylate metabolic process (GO:0046487) | 2.88388186 |
| 100 | tryptophan metabolic process (GO:0006568) | 2.88300772 |
| 101 | startle response (GO:0001964) | 2.87690030 |
| 102 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.87103358 |
| 103 | synaptic transmission (GO:0007268) | 2.87006301 |
| 104 | vesicle transport along microtubule (GO:0047496) | 2.85993543 |
| 105 | learning (GO:0007612) | 2.85255838 |
| 106 | cell migration in hindbrain (GO:0021535) | 2.84941177 |
| 107 | fear response (GO:0042596) | 2.82652038 |
| 108 | establishment of synaptic vesicle localization (GO:0097480) | 2.82455834 |
| 109 | synaptic vesicle transport (GO:0048489) | 2.82455834 |
| 110 | androgen biosynthetic process (GO:0006702) | 2.82212642 |
| 111 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.81540814 |
| 112 | striatum development (GO:0021756) | 2.81308816 |
| 113 | positive regulation of synaptic transmission (GO:0050806) | 2.80459087 |
| 114 | regulation of synaptic transmission (GO:0050804) | 2.80054721 |
| 115 | L-methionine salvage (GO:0071267) | 2.79976481 |
| 116 | L-methionine biosynthetic process (GO:0071265) | 2.79976481 |
| 117 | amino acid salvage (GO:0043102) | 2.79976481 |
| 118 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.79534017 |
| 119 | reflex (GO:0060004) | 2.79235637 |
| 120 | transferrin transport (GO:0033572) | 2.79040578 |
| 121 | positive regulation of neurotransmitter transport (GO:0051590) | 2.79036010 |
| 122 | membrane depolarization (GO:0051899) | 2.77694246 |
| 123 | synaptic transmission, dopaminergic (GO:0001963) | 2.76725691 |
| 124 | indole-containing compound metabolic process (GO:0042430) | 2.76581820 |
| 125 | aromatic amino acid family catabolic process (GO:0009074) | 2.75719779 |
| 126 | omega-hydroxylase P450 pathway (GO:0097267) | 2.75371198 |
| 127 | protein targeting to Golgi (GO:0000042) | 2.75025002 |
| 128 | regulation of pigment cell differentiation (GO:0050932) | 2.74538031 |
| 129 | response to pheromone (GO:0019236) | 2.74016975 |
| 130 | macroautophagy (GO:0016236) | 2.72374965 |
| 131 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.69141126 |
| 132 | oxidative demethylation (GO:0070989) | 2.67208791 |
| 133 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.65205599 |
| 134 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.65205599 |
| 135 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.65205599 |
| 136 | serotonin metabolic process (GO:0042428) | 2.64253883 |
| 137 | ketone body metabolic process (GO:1902224) | 2.61586860 |
| 138 | sex differentiation (GO:0007548) | 2.60874874 |
| 139 | S-adenosylmethionine metabolic process (GO:0046500) | 2.54616162 |
| 140 | cellular response to sterol (GO:0036315) | 2.53387296 |
| 141 | kynurenine metabolic process (GO:0070189) | 2.50752811 |
| 142 | benzene-containing compound metabolic process (GO:0042537) | 2.50608024 |
| 143 | bile acid metabolic process (GO:0008206) | 2.46049189 |
| 144 | protein localization to Golgi apparatus (GO:0034067) | 2.46048948 |
| 145 | flavonoid metabolic process (GO:0009812) | 2.45706179 |
| 146 | triglyceride homeostasis (GO:0070328) | 2.45437510 |
| 147 | acylglycerol homeostasis (GO:0055090) | 2.45437510 |
| 148 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.44790290 |
| 149 | retinal cone cell development (GO:0046549) | 2.43741447 |
| 150 | epoxygenase P450 pathway (GO:0019373) | 2.42812694 |
| 151 | primary amino compound metabolic process (GO:1901160) | 2.41067557 |
| 152 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.40132602 |
| 153 | regulation of hippo signaling (GO:0035330) | 2.36573866 |
| 154 | C4-dicarboxylate transport (GO:0015740) | 2.36415235 |
| 155 | photoreceptor cell maintenance (GO:0045494) | 2.36102030 |
| 156 | coenzyme catabolic process (GO:0009109) | 2.35964034 |
| 157 | organic cation transport (GO:0015695) | 2.32225125 |
| 158 | detection of light stimulus involved in visual perception (GO:0050908) | 2.32216956 |
| 159 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.32216956 |
| 160 | regulation of establishment of cell polarity (GO:2000114) | 2.31472975 |
| 161 | phenylpropanoid metabolic process (GO:0009698) | 2.30911642 |
| 162 | Golgi to endosome transport (GO:0006895) | 2.30524174 |
| 163 | cellular glucuronidation (GO:0052695) | 2.30161610 |
| 164 | cAMP catabolic process (GO:0006198) | 2.29508802 |
| 165 | negative regulation of sodium ion transport (GO:0010766) | 2.28662662 |
| 166 | cellular biogenic amine catabolic process (GO:0042402) | 2.27589756 |
| 167 | amine catabolic process (GO:0009310) | 2.27589756 |
| 168 | interkinetic nuclear migration (GO:0022027) | 2.27124846 |
| 169 | acrosome reaction (GO:0007340) | 2.26246653 |
| 170 | regulation of sarcomere organization (GO:0060297) | 2.24665603 |
| 171 | glycosphingolipid biosynthetic process (GO:0006688) | 2.24127834 |
| 172 | behavioral response to nicotine (GO:0035095) | 2.24096886 |
| 173 | thyroid hormone metabolic process (GO:0042403) | 2.24040030 |
| 174 | membrane depolarization during action potential (GO:0086010) | 2.22626238 |
| 175 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.22548160 |
| 176 | piRNA metabolic process (GO:0034587) | 2.21751435 |
| 177 | dicarboxylic acid catabolic process (GO:0043649) | 2.21265231 |
| 178 | regulation of protein activation cascade (GO:2000257) | 2.20954453 |
| 179 | cyclic nucleotide catabolic process (GO:0009214) | 2.20928909 |
| 180 | androgen metabolic process (GO:0008209) | 2.20321130 |
| 181 | embryonic epithelial tube formation (GO:0001838) | 2.20310166 |
| 182 | ethanol oxidation (GO:0006069) | 2.20268283 |
| 183 | phospholipid translocation (GO:0045332) | 2.18482608 |
| 184 | lipid translocation (GO:0034204) | 2.18482608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.47260048 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.87677225 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15751204 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.06567901 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.91264809 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.64593340 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62212967 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.61247172 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.59708617 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.59708617 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50784134 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47508994 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47178969 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44047283 |
| 15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.43197888 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42269761 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27820656 |
| 18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.22007745 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.19606472 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16989034 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.13312381 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11640544 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.05518646 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.01825584 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.97951046 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.92334068 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89392915 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83975959 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83852164 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.78803682 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.77397856 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.69310993 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.69138316 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68450327 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68098779 |
| 36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.64128780 |
| 37 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.63329245 |
| 38 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.62018124 |
| 39 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.60526665 |
| 40 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.60063123 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57750768 |
| 42 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.57009046 |
| 43 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.57009046 |
| 44 | EWS_26573619_Chip-Seq_HEK293_Human | 1.56509841 |
| 45 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.54884874 |
| 46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52359643 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52212578 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52108938 |
| 49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51303096 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.51238511 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49683573 |
| 52 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.49355590 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47014233 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.45039278 |
| 55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.42593080 |
| 56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.41854730 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40617060 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39232510 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38444267 |
| 60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38052092 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37410243 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35638284 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35167788 |
| 64 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.34798767 |
| 65 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32660883 |
| 66 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.32281593 |
| 67 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.30888405 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30641061 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25676176 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25662221 |
| 71 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25589979 |
| 72 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24814198 |
| 73 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24572902 |
| 74 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22635639 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21707163 |
| 76 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21700403 |
| 77 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.21685009 |
| 78 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21330595 |
| 79 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21330595 |
| 80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20814411 |
| 81 | FUS_26573619_Chip-Seq_HEK293_Human | 1.20560708 |
| 82 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19576663 |
| 83 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.18497275 |
| 84 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18065721 |
| 85 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17878524 |
| 86 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17794104 |
| 87 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16088116 |
| 88 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15673877 |
| 89 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15065663 |
| 90 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.13424420 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.13063642 |
| 92 | * AR_19668381_ChIP-Seq_PC3_Human | 1.12056845 |
| 93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11890640 |
| 94 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11832918 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11718841 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11718841 |
| 97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11276742 |
| 98 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11186930 |
| 99 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10313977 |
| 100 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10147892 |
| 101 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09478030 |
| 102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08091115 |
| 103 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07478912 |
| 104 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.07421851 |
| 105 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07258947 |
| 106 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07141309 |
| 107 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06880354 |
| 108 | JUN_21703547_ChIP-Seq_K562_Human | 1.06583727 |
| 109 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06425735 |
| 110 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06387189 |
| 111 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06292805 |
| 112 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05931911 |
| 113 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04742924 |
| 114 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04739533 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03925613 |
| 116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03754374 |
| 117 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.03649535 |
| 118 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03643098 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02531145 |
| 120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02373589 |
| 121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02344635 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01606843 |
| 123 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01158195 |
| 124 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.00845413 |
| 125 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00458568 |
| 126 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00155928 |
| 127 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99830678 |
| 128 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99437385 |
| 129 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95999150 |
| 130 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94584652 |
| 131 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94083491 |
| 132 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91342240 |
| 133 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90911175 |
| 134 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90237486 |
| 135 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89862242 |
| 136 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89431629 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86593185 |
| 138 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86561211 |
| 139 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.84509209 |
| 140 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.82855813 |
| 141 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.82397117 |
| 142 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81519938 |
| 143 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.81435818 |
| 144 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.81158334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.40342166 |
| 2 | MP0003880_abnormal_central_pattern | 4.69371103 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.79244541 |
| 4 | MP0004270_analgesia | 3.56639759 |
| 5 | MP0002822_catalepsy | 3.52093426 |
| 6 | MP0009745_abnormal_behavioral_response | 3.24469686 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.11461699 |
| 8 | MP0002064_seizures | 3.07386384 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.03923035 |
| 10 | MP0003195_calcinosis | 2.90395357 |
| 11 | MP0009046_muscle_twitch | 2.80824991 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.73572464 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.58504273 |
| 14 | MP0002272_abnormal_nervous_system | 2.56207097 |
| 15 | MP0002736_abnormal_nociception_after | 2.55740008 |
| 16 | MP0003252_abnormal_bile_duct | 2.46149084 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.41081823 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.38671778 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 2.33849868 |
| 20 | MP0001486_abnormal_startle_reflex | 2.28726592 |
| 21 | MP0003868_abnormal_feces_composition | 2.15883176 |
| 22 | MP0005085_abnormal_gallbladder_physiolo | 2.14877611 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.13877073 |
| 24 | MP0002733_abnormal_thermal_nociception | 2.04172207 |
| 25 | MP0006276_abnormal_autonomic_nervous | 2.03229517 |
| 26 | MP0005187_abnormal_penis_morphology | 2.01968107 |
| 27 | MP0001501_abnormal_sleep_pattern | 2.01939053 |
| 28 | MP0008877_abnormal_DNA_methylation | 2.00999873 |
| 29 | MP0001970_abnormal_pain_threshold | 2.00866761 |
| 30 | MP0001529_abnormal_vocalization | 1.95739313 |
| 31 | MP0000778_abnormal_nervous_system | 1.95727675 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.91994686 |
| 33 | MP0003329_amyloid_beta_deposits | 1.86082071 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.82226791 |
| 35 | MP0005670_abnormal_white_adipose | 1.80809492 |
| 36 | MP0002184_abnormal_innervation | 1.80269165 |
| 37 | MP0004924_abnormal_behavior | 1.79125484 |
| 38 | MP0005386_behavior/neurological_phenoty | 1.79125484 |
| 39 | MP0003122_maternal_imprinting | 1.72683825 |
| 40 | MP0010386_abnormal_urinary_bladder | 1.70641412 |
| 41 | MP0001984_abnormal_olfaction | 1.70031895 |
| 42 | MP0002557_abnormal_social/conspecific_i | 1.67657292 |
| 43 | MP0004811_abnormal_neuron_physiology | 1.66884729 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.64943671 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.63114658 |
| 46 | MP0003646_muscle_fatigue | 1.61107510 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.60451815 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.59680913 |
| 49 | MP0001905_abnormal_dopamine_level | 1.58099291 |
| 50 | MP0005360_urolithiasis | 1.57322775 |
| 51 | MP0002102_abnormal_ear_morphology | 1.55680512 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.55274831 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.55221785 |
| 54 | MP0003787_abnormal_imprinting | 1.54613795 |
| 55 | MP0005365_abnormal_bile_salt | 1.54133660 |
| 56 | MP0000955_abnormal_spinal_cord | 1.52016544 |
| 57 | MP0008569_lethality_at_weaning | 1.44570142 |
| 58 | MP0003136_yellow_coat_color | 1.44166981 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.43428099 |
| 60 | MP0002882_abnormal_neuron_morphology | 1.43222293 |
| 61 | MP0004858_abnormal_nervous_system | 1.41031348 |
| 62 | MP0001666_abnormal_nutrient_absorption | 1.40451432 |
| 63 | MP0004885_abnormal_endolymph | 1.38017141 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 1.37868443 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.36396898 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.35337452 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.33049335 |
| 68 | MP0001188_hyperpigmentation | 1.32735733 |
| 69 | MP0003879_abnormal_hair_cell | 1.29798335 |
| 70 | MP0004142_abnormal_muscle_tone | 1.28018093 |
| 71 | MP0002160_abnormal_reproductive_system | 1.19625210 |
| 72 | MP0003633_abnormal_nervous_system | 1.16361549 |
| 73 | MP0003890_abnormal_embryonic-extraembry | 1.14045718 |
| 74 | MP0001986_abnormal_taste_sensitivity | 1.13725404 |
| 75 | MP0005410_abnormal_fertilization | 1.10617698 |
| 76 | MP0002152_abnormal_brain_morphology | 1.10504644 |
| 77 | MP0000427_abnormal_hair_cycle | 1.10264026 |
| 78 | MP0002009_preneoplasia | 1.10018432 |
| 79 | MP0005394_taste/olfaction_phenotype | 1.09031491 |
| 80 | MP0005499_abnormal_olfactory_system | 1.09031491 |
| 81 | MP0002229_neurodegeneration | 1.08996434 |
| 82 | MP0003283_abnormal_digestive_organ | 1.07214963 |
| 83 | MP0002928_abnormal_bile_duct | 1.06743812 |
| 84 | MP0000751_myopathy | 1.06562695 |
| 85 | MP0005253_abnormal_eye_physiology | 1.05069936 |
| 86 | MP0005551_abnormal_eye_electrophysiolog | 1.05068052 |
| 87 | MP0004043_abnormal_pH_regulation | 1.05008728 |
| 88 | MP0003631_nervous_system_phenotype | 1.03627518 |
| 89 | MP0003718_maternal_effect | 1.02778535 |
| 90 | MP0001664_abnormal_digestion | 1.00385502 |
| 91 | MP0001502_abnormal_circadian_rhythm | 0.99976572 |
| 92 | MP0000920_abnormal_myelination | 0.99257726 |
| 93 | MP0003698_abnormal_male_reproductive | 0.98203014 |
| 94 | MP0001764_abnormal_homeostasis | 0.98086742 |
| 95 | MP0003634_abnormal_glial_cell | 0.96256218 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.95753991 |
| 97 | MP0000631_abnormal_neuroendocrine_gland | 0.95680046 |
| 98 | MP0004742_abnormal_vestibular_system | 0.94382148 |
| 99 | MP0001756_abnormal_urination | 0.93951519 |
| 100 | MP0001963_abnormal_hearing_physiology | 0.93289949 |
| 101 | MP0003011_delayed_dark_adaptation | 0.90830525 |
| 102 | MP0002069_abnormal_eating/drinking_beha | 0.89986411 |
| 103 | MP0000383_abnormal_hair_follicle | 0.89228087 |
| 104 | MP0008872_abnormal_physiological_respon | 0.88006452 |
| 105 | MP0005647_abnormal_sex_gland | 0.86269481 |
| 106 | MP0004145_abnormal_muscle_electrophysio | 0.86154475 |
| 107 | MP0002752_abnormal_somatic_nervous | 0.86100241 |
| 108 | MP0005389_reproductive_system_phenotype | 0.86030790 |
| 109 | MP0009697_abnormal_copulation | 0.84816549 |
| 110 | MP0004019_abnormal_vitamin_homeostasis | 0.83811258 |
| 111 | MP0002118_abnormal_lipid_homeostasis | 0.83793200 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.82554024 |
| 113 | MP0003045_fibrosis | 0.81413875 |
| 114 | MP0006072_abnormal_retinal_apoptosis | 0.81342947 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.80967452 |
| 116 | MP0005171_absent_coat_pigmentation | 0.80785284 |
| 117 | MP0004130_abnormal_muscle_cell | 0.80440234 |
| 118 | MP0004233_abnormal_muscle_weight | 0.79877157 |
| 119 | MP0005332_abnormal_amino_acid | 0.79437000 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.78607888 |
| 121 | MP0001177_atelectasis | 0.78336857 |
| 122 | MP0001919_abnormal_reproductive_system | 0.76865580 |
| 123 | MP0003632_abnormal_nervous_system | 0.76848082 |
| 124 | MP0001485_abnormal_pinna_reflex | 0.75138375 |
| 125 | MP0000604_amyloidosis | 0.71231799 |
| 126 | MP0004085_abnormal_heartbeat | 0.68729803 |
| 127 | MP0008789_abnormal_olfactory_epithelium | 0.67945112 |
| 128 | MP0008874_decreased_physiological_sensi | 0.67762985 |
| 129 | MP0001299_abnormal_eye_distance/ | 0.66344163 |
| 130 | MP0005535_abnormal_body_temperature | 0.65274060 |
| 131 | MP0001943_abnormal_respiration | 0.62164639 |
| 132 | MP0003861_abnormal_nervous_system | 0.60708024 |
| 133 | MP0002090_abnormal_vision | 0.60479570 |
| 134 | MP0003121_genomic_imprinting | 0.56956986 |
| 135 | MP0002751_abnormal_autonomic_nervous | 0.53364943 |
| 136 | MP0000026_abnormal_inner_ear | 0.53126460 |
| 137 | MP0000003_abnormal_adipose_tissue | 0.52960812 |
| 138 | MP0005409_darkened_coat_color | 0.52890169 |
| 139 | MP0000538_abnormal_urinary_bladder | 0.51557719 |
| 140 | MP0004484_altered_response_of | 0.50298081 |
| 141 | MP0004215_abnormal_myocardial_fiber | 0.50172599 |
| 142 | MP0002638_abnormal_pupillary_reflex | 0.50087909 |
| 143 | MP0003690_abnormal_glial_cell | 0.48733029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.08149783 |
| 2 | Myokymia (HP:0002411) | 6.05037363 |
| 3 | Focal seizures (HP:0007359) | 5.10664963 |
| 4 | Visual hallucinations (HP:0002367) | 4.88870604 |
| 5 | Atonic seizures (HP:0010819) | 4.77106151 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.46101946 |
| 7 | Absence seizures (HP:0002121) | 4.00252206 |
| 8 | Febrile seizures (HP:0002373) | 3.80357876 |
| 9 | Type II lissencephaly (HP:0007260) | 3.75516123 |
| 10 | Dialeptic seizures (HP:0011146) | 3.74216717 |
| 11 | Hyperventilation (HP:0002883) | 3.58044996 |
| 12 | Chronic hepatic failure (HP:0100626) | 3.56816075 |
| 13 | Pheochromocytoma (HP:0002666) | 3.52767791 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.48792064 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.39340071 |
| 16 | Ankle clonus (HP:0011448) | 3.34674656 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.32206210 |
| 18 | Neuroendocrine neoplasm (HP:0100634) | 3.23985975 |
| 19 | Action tremor (HP:0002345) | 3.04615989 |
| 20 | Broad-based gait (HP:0002136) | 2.96640520 |
| 21 | Cerebral inclusion bodies (HP:0100314) | 2.92704306 |
| 22 | Cerebellar dysplasia (HP:0007033) | 2.90659153 |
| 23 | Poor eye contact (HP:0000817) | 2.87372866 |
| 24 | Anxiety (HP:0000739) | 2.86830745 |
| 25 | Fair hair (HP:0002286) | 2.86260755 |
| 26 | Truncal ataxia (HP:0002078) | 2.85299015 |
| 27 | Insidious onset (HP:0003587) | 2.83369942 |
| 28 | Termporal pattern (HP:0011008) | 2.83369942 |
| 29 | Neurofibrillary tangles (HP:0002185) | 2.75446590 |
| 30 | Depression (HP:0000716) | 2.74265990 |
| 31 | Limb dystonia (HP:0002451) | 2.71395143 |
| 32 | Progressive inability to walk (HP:0002505) | 2.68868911 |
| 33 | Dysmetria (HP:0001310) | 2.66680557 |
| 34 | Amblyopia (HP:0000646) | 2.65782534 |
| 35 | Impaired social interactions (HP:0000735) | 2.64500808 |
| 36 | Abnormal social behavior (HP:0012433) | 2.64500808 |
| 37 | Abnormal eating behavior (HP:0100738) | 2.63767739 |
| 38 | Epileptiform EEG discharges (HP:0011182) | 2.62759390 |
| 39 | Spastic gait (HP:0002064) | 2.60653693 |
| 40 | Abnormality of the corticospinal tract (HP:0002492) | 2.59815881 |
| 41 | Hyperglycinemia (HP:0002154) | 2.59237725 |
| 42 | Hypothermia (HP:0002045) | 2.56594835 |
| 43 | Dysmetric saccades (HP:0000641) | 2.54631035 |
| 44 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.52892112 |
| 45 | EEG with generalized epileptiform discharges (HP:0011198) | 2.50667496 |
| 46 | Prolonged partial thromboplastin time (HP:0003645) | 2.49957235 |
| 47 | Gaze-evoked nystagmus (HP:0000640) | 2.46398236 |
| 48 | Pancreatic cysts (HP:0001737) | 2.46227702 |
| 49 | Scanning speech (HP:0002168) | 2.45889774 |
| 50 | Drooling (HP:0002307) | 2.45554658 |
| 51 | Excessive salivation (HP:0003781) | 2.45554658 |
| 52 | Abolished electroretinogram (ERG) (HP:0000550) | 2.43625343 |
| 53 | Gait imbalance (HP:0002141) | 2.43441710 |
| 54 | Protruding tongue (HP:0010808) | 2.39652867 |
| 55 | Hypsarrhythmia (HP:0002521) | 2.35314248 |
| 56 | Dysdiadochokinesis (HP:0002075) | 2.34172581 |
| 57 | Abnormality of the renal cortex (HP:0011035) | 2.31459082 |
| 58 | Abnormal hair whorl (HP:0010721) | 2.31373600 |
| 59 | Generalized hypopigmentation of hair (HP:0011358) | 2.29373784 |
| 60 | Failure to thrive in infancy (HP:0001531) | 2.27245675 |
| 61 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.27202130 |
| 62 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.27202130 |
| 63 | Polyphagia (HP:0002591) | 2.27182383 |
| 64 | Mutism (HP:0002300) | 2.26569568 |
| 65 | Lower limb muscle weakness (HP:0007340) | 2.24833323 |
| 66 | Hypoventilation (HP:0002791) | 2.23746796 |
| 67 | Retinal atrophy (HP:0001105) | 2.21846094 |
| 68 | Proximal tubulopathy (HP:0000114) | 2.21724493 |
| 69 | True hermaphroditism (HP:0010459) | 2.20356393 |
| 70 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.19878084 |
| 71 | Urinary urgency (HP:0000012) | 2.19786618 |
| 72 | Abnormality of binocular vision (HP:0011514) | 2.19611409 |
| 73 | Diplopia (HP:0000651) | 2.19611409 |
| 74 | Postural instability (HP:0002172) | 2.19125682 |
| 75 | Epidermoid cyst (HP:0200040) | 2.18826511 |
| 76 | Abnormal biliary tract physiology (HP:0012439) | 2.17897293 |
| 77 | Bile duct proliferation (HP:0001408) | 2.17897293 |
| 78 | Nephronophthisis (HP:0000090) | 2.16772499 |
| 79 | Torticollis (HP:0000473) | 2.15874161 |
| 80 | Intrahepatic cholestasis (HP:0001406) | 2.15498048 |
| 81 | Tubulointerstitial nephritis (HP:0001970) | 2.13742877 |
| 82 | Inability to walk (HP:0002540) | 2.12772877 |
| 83 | Hypobetalipoproteinemia (HP:0003563) | 2.11533731 |
| 84 | Abnormality of the lower motor neuron (HP:0002366) | 2.10678942 |
| 85 | Pancreatic fibrosis (HP:0100732) | 2.09279095 |
| 86 | Renal cortical cysts (HP:0000803) | 2.08390299 |
| 87 | Abnormal pancreas size (HP:0012094) | 2.07543521 |
| 88 | Abnormality of glycine metabolism (HP:0010895) | 2.06630585 |
| 89 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.06630585 |
| 90 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.05832566 |
| 91 | Bradykinesia (HP:0002067) | 2.04957175 |
| 92 | Medial flaring of the eyebrow (HP:0010747) | 2.04636091 |
| 93 | Abnormal drinking behavior (HP:0030082) | 2.04354558 |
| 94 | Polydipsia (HP:0001959) | 2.04354558 |
| 95 | Focal dystonia (HP:0004373) | 2.04050805 |
| 96 | Widely spaced teeth (HP:0000687) | 2.03670692 |
| 97 | Delusions (HP:0000746) | 2.03329209 |
| 98 | Abnormality of the renal medulla (HP:0100957) | 2.02301300 |
| 99 | Congenital primary aphakia (HP:0007707) | 2.01590275 |
| 100 | Decreased circulating renin level (HP:0003351) | 2.01542726 |
| 101 | Specific learning disability (HP:0001328) | 2.01498443 |
| 102 | Cupped ear (HP:0000378) | 2.00902206 |
| 103 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.99667660 |
| 104 | Psychosis (HP:0000709) | 1.99577793 |
| 105 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.99261529 |
| 106 | Hemiparesis (HP:0001269) | 1.98476010 |
| 107 | Ketosis (HP:0001946) | 1.98039298 |
| 108 | Poor coordination (HP:0002370) | 1.98033658 |
| 109 | Acute necrotizing encephalopathy (HP:0006965) | 1.97693063 |
| 110 | Absent speech (HP:0001344) | 1.97294420 |
| 111 | Megalencephaly (HP:0001355) | 1.97011822 |
| 112 | Retinal dysplasia (HP:0007973) | 1.95571510 |
| 113 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.94757784 |
| 114 | Abnormality of alanine metabolism (HP:0010916) | 1.94757784 |
| 115 | Hyperalaninemia (HP:0003348) | 1.94757784 |
| 116 | Calf muscle hypertrophy (HP:0008981) | 1.94350988 |
| 117 | Resting tremor (HP:0002322) | 1.93734339 |
| 118 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.93398118 |
| 119 | Gonadotropin excess (HP:0000837) | 1.91499815 |
| 120 | Generalized myoclonic seizures (HP:0002123) | 1.91289770 |
| 121 | Akinesia (HP:0002304) | 1.90921185 |
| 122 | Male pseudohermaphroditism (HP:0000037) | 1.90704774 |
| 123 | Clumsiness (HP:0002312) | 1.89924426 |
| 124 | Stereotypic behavior (HP:0000733) | 1.89913064 |
| 125 | Craniofacial dystonia (HP:0012179) | 1.89246693 |
| 126 | Hypoplasia of the pons (HP:0012110) | 1.88040370 |
| 127 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.86303405 |
| 128 | Lower limb hyperreflexia (HP:0002395) | 1.85980496 |
| 129 | Abnormality of the pons (HP:0007361) | 1.84997728 |
| 130 | Nephrogenic diabetes insipidus (HP:0009806) | 1.84796921 |
| 131 | Hyperglycinuria (HP:0003108) | 1.84273593 |
| 132 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.84255015 |
| 133 | Rapidly progressive (HP:0003678) | 1.83911612 |
| 134 | Abnormality of midbrain morphology (HP:0002418) | 1.83549958 |
| 135 | Molar tooth sign on MRI (HP:0002419) | 1.83549958 |
| 136 | Hyperkalemia (HP:0002153) | 1.83027044 |
| 137 | Thickened helices (HP:0000391) | 1.82292131 |
| 138 | Tubular atrophy (HP:0000092) | 1.82272549 |
| 139 | Fetal akinesia sequence (HP:0001989) | 1.82161920 |
| 140 | Hyperthyroidism (HP:0000836) | 1.81999432 |
| 141 | Peripheral hypomyelination (HP:0007182) | 1.81249269 |
| 142 | Abnormality of the axillary hair (HP:0100134) | 1.80664376 |
| 143 | Abnormality of secondary sexual hair (HP:0009888) | 1.80664376 |
| 144 | Clonus (HP:0002169) | 1.80560234 |
| 145 | Gait ataxia (HP:0002066) | 1.80526168 |
| 146 | Blue irides (HP:0000635) | 1.80216698 |
| 147 | Progressive macrocephaly (HP:0004481) | 1.79401223 |
| 148 | Genetic anticipation (HP:0003743) | 1.78602079 |
| 149 | Enlarged kidneys (HP:0000105) | 1.77851311 |
| 150 | Ketoacidosis (HP:0001993) | 1.77631992 |
| 151 | Agitation (HP:0000713) | 1.77614920 |
| 152 | Syncope (HP:0001279) | 1.77528500 |
| 153 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77515716 |
| 154 | Methylmalonic acidemia (HP:0002912) | 1.77134369 |
| 155 | Vaginal atresia (HP:0000148) | 1.77057603 |
| 156 | Hepatoblastoma (HP:0002884) | 1.76543325 |
| 157 | Facial shape deformation (HP:0011334) | 1.75637117 |
| 158 | Potter facies (HP:0002009) | 1.75637117 |
| 159 | Absent eyebrow (HP:0002223) | 1.75420375 |
| 160 | Genital tract atresia (HP:0001827) | 1.74500906 |
| 161 | Impaired smooth pursuit (HP:0007772) | 1.73648209 |
| 162 | Sensory axonal neuropathy (HP:0003390) | 1.73255092 |
| 163 | Abnormality of serum amino acid levels (HP:0003112) | 1.73142828 |
| 164 | Large for gestational age (HP:0001520) | 1.72549169 |
| 165 | Intention tremor (HP:0002080) | 1.72129858 |
| 166 | Papillary thyroid carcinoma (HP:0002895) | 1.71960874 |
| 167 | Poor suck (HP:0002033) | 1.71526839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.18806710 |
| 2 | EPHA4 | 3.47349204 |
| 3 | MAP3K4 | 3.29518632 |
| 4 | MAP3K9 | 3.18904306 |
| 5 | CASK | 3.12245908 |
| 6 | PINK1 | 3.10822588 |
| 7 | MARK1 | 3.07475968 |
| 8 | MAP2K7 | 2.69815771 |
| 9 | ARAF | 2.55139428 |
| 10 | MAP3K12 | 2.54256414 |
| 11 | STK38L | 2.51815276 |
| 12 | MINK1 | 2.41472845 |
| 13 | KSR2 | 1.96143846 |
| 14 | ACVR1B | 1.94927243 |
| 15 | DAPK2 | 1.91524264 |
| 16 | PLK2 | 1.89959983 |
| 17 | MAP4K2 | 1.77045715 |
| 18 | NTRK1 | 1.75246971 |
| 19 | LATS1 | 1.73741834 |
| 20 | MAP2K4 | 1.73602453 |
| 21 | CDK19 | 1.72479668 |
| 22 | PAK6 | 1.71485895 |
| 23 | NTRK2 | 1.67631788 |
| 24 | PNCK | 1.64278777 |
| 25 | GRK5 | 1.60425006 |
| 26 | KSR1 | 1.53390284 |
| 27 | CDK5 | 1.51796762 |
| 28 | PRPF4B | 1.51037269 |
| 29 | NLK | 1.48656469 |
| 30 | DAPK1 | 1.46763711 |
| 31 | OXSR1 | 1.46668798 |
| 32 | MAPK13 | 1.42805766 |
| 33 | TAOK3 | 1.40555437 |
| 34 | PRKD3 | 1.39306527 |
| 35 | MAP3K2 | 1.38410874 |
| 36 | RIPK4 | 1.33113497 |
| 37 | CAMK1G | 1.24519373 |
| 38 | OBSCN | 1.17627212 |
| 39 | UHMK1 | 1.16750904 |
| 40 | NUAK1 | 1.15618712 |
| 41 | MKNK2 | 1.14388964 |
| 42 | CAMK2A | 1.13987252 |
| 43 | CSNK1A1L | 1.09547897 |
| 44 | GRK1 | 1.07352598 |
| 45 | FGFR2 | 1.07141769 |
| 46 | MAP3K13 | 1.06995282 |
| 47 | PRKCG | 1.06451388 |
| 48 | CAMK2B | 1.06316851 |
| 49 | BCR | 1.06228548 |
| 50 | CDK14 | 1.05145200 |
| 51 | NME1 | 1.03505618 |
| 52 | CDK18 | 1.02971650 |
| 53 | TNIK | 1.02691960 |
| 54 | PTK2B | 1.02538333 |
| 55 | CDK15 | 0.98780216 |
| 56 | MARK3 | 0.98741110 |
| 57 | PAK3 | 0.97634286 |
| 58 | SGK494 | 0.96854356 |
| 59 | SGK223 | 0.96854356 |
| 60 | CSNK1G1 | 0.96755070 |
| 61 | CAMKK1 | 0.95311094 |
| 62 | STK39 | 0.94047213 |
| 63 | SIK2 | 0.93907486 |
| 64 | BRAF | 0.93825735 |
| 65 | TYRO3 | 0.93311131 |
| 66 | BMPR2 | 0.92797521 |
| 67 | CAMK1D | 0.92308687 |
| 68 | FGR | 0.88823609 |
| 69 | SGK3 | 0.88376448 |
| 70 | CDK11A | 0.84735640 |
| 71 | CDK3 | 0.84611881 |
| 72 | EIF2AK3 | 0.84101944 |
| 73 | CSNK1G2 | 0.83820988 |
| 74 | FES | 0.83328795 |
| 75 | LIMK1 | 0.83225997 |
| 76 | PHKG1 | 0.81131329 |
| 77 | PHKG2 | 0.81131329 |
| 78 | PIK3CA | 0.80843423 |
| 79 | EPHA3 | 0.79504726 |
| 80 | PRKCE | 0.79082567 |
| 81 | CAMK2D | 0.78944082 |
| 82 | DYRK1A | 0.78608493 |
| 83 | FER | 0.75452807 |
| 84 | CAMKK2 | 0.74932236 |
| 85 | STK24 | 0.74670797 |
| 86 | LATS2 | 0.73892025 |
| 87 | RET | 0.73558259 |
| 88 | LMTK2 | 0.72361557 |
| 89 | AKT3 | 0.71868417 |
| 90 | BRD4 | 0.71435654 |
| 91 | CCNB1 | 0.71159783 |
| 92 | MAP3K7 | 0.70551146 |
| 93 | MAPK15 | 0.69907021 |
| 94 | INSRR | 0.69850146 |
| 95 | TAOK1 | 0.69832578 |
| 96 | PRKAA2 | 0.69427072 |
| 97 | PRKCH | 0.68739073 |
| 98 | RAF1 | 0.68708887 |
| 99 | WNK4 | 0.66348518 |
| 100 | MARK2 | 0.64677029 |
| 101 | PRKAA1 | 0.63269044 |
| 102 | SIK3 | 0.61166948 |
| 103 | STK11 | 0.58683747 |
| 104 | MAP2K1 | 0.57809878 |
| 105 | CSNK1G3 | 0.57486693 |
| 106 | FGFR3 | 0.57409081 |
| 107 | DDR2 | 0.57317101 |
| 108 | WNK3 | 0.56910158 |
| 109 | CAMK2G | 0.56200419 |
| 110 | ROCK2 | 0.56031941 |
| 111 | STK3 | 0.55887738 |
| 112 | RPS6KB1 | 0.55566206 |
| 113 | DAPK3 | 0.53266538 |
| 114 | MYLK | 0.52975408 |
| 115 | MAP3K1 | 0.51903858 |
| 116 | STK38 | 0.51372564 |
| 117 | CAMK4 | 0.51257611 |
| 118 | NEK6 | 0.49386399 |
| 119 | SGK1 | 0.48486460 |
| 120 | TRIM28 | 0.48190039 |
| 121 | ADRBK1 | 0.48080006 |
| 122 | YES1 | 0.47794727 |
| 123 | PKN1 | 0.47783307 |
| 124 | CAMK1 | 0.46640577 |
| 125 | CSNK1D | 0.46530971 |
| 126 | FYN | 0.46310542 |
| 127 | CSNK1A1 | 0.45791815 |
| 128 | SGK2 | 0.44707489 |
| 129 | TNK2 | 0.44447792 |
| 130 | ZAK | 0.43696258 |
| 131 | ERBB3 | 0.43653972 |
| 132 | DMPK | 0.43553068 |
| 133 | PRKG1 | 0.43415627 |
| 134 | TSSK6 | 0.42642575 |
| 135 | IRAK1 | 0.42588094 |
| 136 | PDPK1 | 0.42538737 |
| 137 | MAPKAPK5 | 0.42066138 |
| 138 | BMPR1B | 0.41853718 |
| 139 | MOS | 0.41359886 |
| 140 | BRSK2 | 0.41166737 |
| 141 | DYRK2 | 0.38933579 |
| 142 | WNK1 | 0.38903884 |
| 143 | TIE1 | 0.38798678 |
| 144 | RPS6KA3 | 0.37741221 |
| 145 | PRKCZ | 0.36341863 |
| 146 | ADRBK2 | 0.36157474 |
| 147 | FRK | 0.35084784 |
| 148 | TRPM7 | 0.34693041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.50951233 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.41735505 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.22748743 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.70234781 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.70170010 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.63314676 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.54591151 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.51501150 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.49368503 |
| 10 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.42544758 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.32583289 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.31099395 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.25551658 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.22425644 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.21260823 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10186509 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09882816 |
| 18 | Retinol metabolism_Homo sapiens_hsa00830 | 2.06268968 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.96403183 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.94400935 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.93658789 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.90817557 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.89277549 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88651050 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.88139900 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.87334784 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.84756939 |
| 28 | Circadian rhythm_Homo sapiens_hsa04710 | 1.83195185 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80659487 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.79163857 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.73777646 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.72372268 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.69765090 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.67986037 |
| 35 | Long-term depression_Homo sapiens_hsa04730 | 1.67474122 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.66248734 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.63086270 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.60522652 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.58354204 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.54103326 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.46692823 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.45434892 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.44102704 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.42759387 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.42601056 |
| 46 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42084390 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41860897 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.38238373 |
| 49 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.35279103 |
| 50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.34642195 |
| 51 | Gap junction_Homo sapiens_hsa04540 | 1.31469663 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29345238 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.29247064 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26799937 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26659537 |
| 56 | Parkinsons disease_Homo sapiens_hsa05012 | 1.24526228 |
| 57 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23912519 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 1.22635314 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.22113363 |
| 60 | Axon guidance_Homo sapiens_hsa04360 | 1.21927149 |
| 61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.21784669 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.19912608 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19197809 |
| 64 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19184214 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 1.18911322 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.14379490 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12968053 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 1.05621397 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03902275 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 1.03734747 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01315327 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00985559 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99917208 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99013201 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96372993 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93349707 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93182869 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91611552 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91218846 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90129023 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.89513787 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.89437203 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87329178 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86633758 |
| 85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.86044591 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83067483 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81489916 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80798292 |
| 89 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78074623 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76856724 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76169998 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75603847 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74033996 |
| 94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73888388 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73660985 |
| 96 | Huntingtons disease_Homo sapiens_hsa05016 | 0.72732449 |
| 97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72678620 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71663485 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71627917 |
| 100 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71023241 |
| 101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68397171 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67700700 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67439557 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67158159 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66473344 |
| 106 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64725071 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64425106 |
| 108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64235625 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64137196 |
| 110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.62594350 |
| 111 | Alcoholism_Homo sapiens_hsa05034 | 0.61520256 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60558046 |
| 113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60392848 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59795524 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59540590 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59522234 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58510349 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57661574 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56058356 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54043761 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53019819 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52262236 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51784273 |
| 124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50732862 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49157667 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.48933426 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48014325 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47684419 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47546749 |
| 130 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46392521 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.46191478 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | 0.45751022 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45664723 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45421478 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44494916 |
| 136 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42900837 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.40671101 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40669222 |
| 139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39776274 |
| 140 | Tight junction_Homo sapiens_hsa04530 | 0.38252247 |
| 141 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36229680 |
| 142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35802429 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35349434 |
| 144 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33871070 |
| 145 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31826228 |
| 146 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30684757 |
| 147 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30521333 |
| 148 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30149692 |
| 149 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.28133125 |
| 150 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.28013355 |
| 151 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27576740 |
| 152 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26714544 |

